Prevention of cardiovascular disease in women

被引:0
|
作者
Omer L. Shedd
Marian C. Limacher
机构
[1] University of Florida College of Medicine,Division of Cardiovascular Medicine, Department of Medicine
关键词
Bile Acid; Niacin; American Heart Association; Ezetimibe; Main Side Effect;
D O I
10.1007/s11936-003-0028-6
中图分类号
学科分类号
摘要
Appropriate screening and lifestyle modification are the foundations of effective cardiovascular disease (CVD) prevention in women. All adult women should undergo a cardiovascular risk assessment, including family history, smoking, diet, and exercise assessments, and measurement of fasting lipid profile, waist and hip dimensions, and blood pressure. Women should be advised of their 10-year estimated risk of developing a cardiovascular event using the Framingham risk calculator as recommended by the National Cholesterol Education Program. Based on the level of risk, women should receive counseling on dietary modification, physical activity, weight loss, and the need for pharmacologic intervention for blood pressure, lipid, and diabetes management. In addition, women who are overweight, have a history of gestational diabetes, or family history of diabetes should have a fasting glucose measured. Women who smoke should receive advice, encouragement, and assistance for smoking cessation. Postmenopausal hormone therapy should not be considered a treatment option for primary or secondary prevention of CVD. Women and their families should be advised of the possible signs of CVD and the need to seek immediate medical attention in the event of prolonged, new, or severe symptoms. Women with coronary artery disease especially need close attention to their risk factor levels and should receive intensive intervention to achieve optimal control.
引用
收藏
页码:287 / 298
页数:11
相关论文
共 50 条
  • [1] The prevention of cardiovascular disease in women
    Matzo, Marianne
    AMERICAN JOURNAL OF NURSING, 2008, 108 (08) : 74 - 74
  • [2] Prevention of Cardiovascular Disease in Women
    Bavry, Anthony A.
    Limacher, Marian C.
    SEMINARS IN REPRODUCTIVE MEDICINE, 2014, 32 (06) : 447 - 453
  • [3] Cardiovascular disease prevention in women
    Ganiats, Theodore G.
    Campos-Outcalt, Douglas
    AMERICAN FAMILY PHYSICIAN, 2007, 75 (07) : 984 - +
  • [4] Cardiovascular Disease in Women Primary and Secondary Cardiovascular Disease Prevention
    Sanghavi, Monika
    Gulati, Martha
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2016, 43 (02) : 265 - +
  • [5] Management and prevention of cardiovascular disease in women
    Price, JAD
    NURSING CLINICS OF NORTH AMERICA, 2004, 39 (04) : 873 - +
  • [6] Primary prevention of cardiovascular disease in women
    Gray, M. P.
    Vogel, B.
    Mehran, R.
    Leopold, J. A.
    Figtree, G. A.
    CLIMACTERIC, 2024, 27 (01) : 104 - 112
  • [7] Update on Cardiovascular Disease Prevention in Women
    Caboral, Meriam F.
    AMERICAN JOURNAL OF NURSING, 2013, 113 (03) : 26 - 33
  • [8] Aspirin in the prevention of cardiovascular disease in women
    Schwartz, DJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2751 - 2751
  • [9] Women and Cardiovascular Disease-Prevention of Heart Disease
    Whayne, Thomas F., Jr.
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2005, 14 (04) : 218 - 224
  • [10] Cardiovascular Disease Prevention in Women What Not to Use
    Gillespie, Nicole D.
    DeSimone, Edward M., II
    US PHARMACIST, 2011, 36 (09) : 44 - 48